HIGHLIGHTS
- who: Report and colleagues from the (UNIVERSITY) have published the research: Review began 11/23/2022 Review ended 11/29/2022 Published 11/30/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/30,/2022
- what: Medullary thyroid carcinoma is a rare thyroid malignancy, and calcitonin-negative medullary thyroid carcinoma is even more rare.
SUMMARY
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that originates from the malignant proliferation of thyroid parafollicular C-cells; it represents 1-10% of all thyroid cancers. The mean survival rate of patients with medullary thyroid . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.